Tcf-3 expression and β -catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)
Open Access
- 3 July 2001
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 85 (1), 98-101
- https://doi.org/10.1054/bjoc.2001.1857
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor)Oncogene, 2001
- Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathwaysOncogene, 1999
- Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)Oncogene, 1999
- Synergy Between Tumor Suppressor APC and the β-Catenin-Tcf4 Target Tcf1Science, 1999
- Restricted High Level Expression of Tcf-4 Protein in Intestinal and Mammary Gland EpitheliumThe American Journal of Pathology, 1999
- The Yin-Yang of TCF/β-Catenin SignalingAdvances in Cancer Research, 1999
- Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APCScience, 1997
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon CarcinomaScience, 1997
- Functional interaction of β-catenin with the transcription factor LEF-1Nature, 1996
- Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate.Genes & Development, 1995